Stock listing
NASDAQ:AMAM Ambrx Biopharma Inc. Stock
Follow Ambrx Biopharma Inc. into a list and get an email when it puts out news.
Last close · NASDAQ:AMAM
$28.00 USD
Close on Mar 6, 2024 · No longer trades
- Lowest – highest close
- $0.41 – $28.09 USDSince Jun 18, 2021 · lowest Dec 8, 2022 · highest Jan 11, 2024
Delisted NASDAQ:AMAM no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:AMAM
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Ambrx Biopharma Inc. on 6ix
- Decks
- 5 decks · latest Feb 15, 2024
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (February 2024) | Merger or acquisition | 18 slides | Feb 15, 2024 |
| Investor Presentation (April 2023) | Investor deck | 32 slides | Apr 10, 2023 |
| Investor Day (February 2023) | Investor day | 19 slides | Feb 24, 2023 |
| Corporate Update (October 2022) | Corporate update | 21 slides | Oct 18, 2022 |
| Investor Presentation (November 2021) | Investor deck | 31 slides | Nov 8, 2021 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Paul V. Maier Other companies: Eton Pharmaceuticals, Inc. (Eton Pharmaceutical Audit Committee Chairman · Since at least Nov 9, 2018); International Stem Cell Corporation (Independent Director · Since at least Jul 19, 2007); AIxCrypto Holdings, Inc. (Director · Jun 24, 2015 – Jan 15, 2020 · Past); MabVax Therapeutics Holdings Inc (Director · Apr 2, 2015 – Apr 2, 2018 · Past); Apricus Biosciences Inc (Director · Jun 1, 2012 – Jan 4, 2018 · Past); Talon Therapeutics Inc (Director · Apr 1, 2011 – Jul 17, 2013 · Past); Sequenom Inc (Chief Financial Officer · Nov 10, 2009 – Feb 10, 2014 · Past); PURE Bioscience (Director · Jan 22, 2008 – Jul 31, 2012 · Past); Ligand Pharmaceuticals Incorporated (Sr. V-P, CFO · Mar 10, 2006 – Nov 20, 2006 · Past) | Director · Jan 1, 2023 – Mar 7, 2024 · Past |
| Stephen C. Glover Other companies: Oncolytics Biotech Inc. (Director · Since at least Jun 1, 2026); ZyVersa Therapeutics, Inc. (Co-founder, Chairman, CEO, and President · Since at least Dec 12, 2022); PDS Biotechnology Corporation (Director · Since at least Apr 2, 2019); Insmed Incorporated (President Follow-on Biologics · Jun 22, 2007 – Mar 31, 2009 · Past) | Director · May 18, 2023 – Mar 7, 2024 · Past |
| Daniel O’Connor Other companies: DiaMedica Therapeutics Inc. (Director · Since at least Feb 20, 2025); ZyVersa Therapeutics, Inc. (Director · Dec 20, 2021 – Dec 12, 2022 · Past) | President and CEO, Director · Jan 1, 2023 – Mar 7, 2024 · Past |
| Edward Hu Other companies: Viela Bio Inc (Director · Oct 2, 2019 – Mar 13, 2021 · Past); Tanox Inc (Chief Operating Officer · Feb 15, 2006 – Nov 28, 2006 · Past) | Director · Jan 1, 2023 – Jan 1, 2023 · Past |
| Sonja Nelson Other companies: Motus GI Holdings, Inc. (Director · Jun 22, 2021 – Mar 5, 2024 · Past); ImmunityBio, Inc. (Chief Financial Officer · Aug 2, 2019 – Jan 12, 2021 · Past) | Chief Financial Officer · Jan 1, 2023 – Mar 7, 2024 · Past |
| Andrew Aromando Other companies: Oncolytics Biotech Inc. (Chief Business Officer · Since at least Jun 30, 2025) | Chief Operating Officer · Apr 28, 2023 – Mar 7, 2024 · Past |
| Katrin Rupalla Other companies: ZyVersa Therapeutics, Inc. (Director · Jan 5, 2023 – Jan 5, 2023 · Past) | Director · Jan 1, 2023 – Jan 27, 2023 · Past |
| Margaret Dalesandro Other companies: Skye Bioscience, Inc. (Director · Aug 7, 2020 – Feb 29, 2024 · Past) | Director · Sep 1, 2023 – Mar 7, 2024 · Past |
| Janet Loesberg | Director · Jan 1, 2023 – Mar 7, 2024 · Past |
| Kate Hermans | Director · Jan 1, 2023 – Mar 7, 2024 · Past |
All 11 people
| Person | Seat |
|---|---|
| Xiaowei Chang | Director · Jan 1, 2023 – Jun 7, 2023 · Past |
Log in to ask 6ix AI your own questions about Ambrx Biopharma Inc.